Medicine Park Co., Ltd.
Medicine Park is a South Korea–based biotech company focused on developing therapeutics for connective tissue disorders using proprietary biopolymer technology. The company concentrates on intra‑articular injectable formulations for human and veterinary use, functional food ingredients for musculoskeletal health, and translational development from preclinical research through regulatory submission.
Industries
N/A
Products
Intra‑articular injectable for knee osteoarthritis (human prescription formulation)
A prescription intra‑articular therapeutic formulation developed for knee osteoarthritis using biopolymer‑based materials.
Veterinary intra‑articular injectable (companion animals and equine)
Intra‑articular formulations developed for veterinary indications including companion dogs and racehorses.
Injectable formulations for shoulder conditions
Joint/soft‑tissue injectable formulations intended for shoulder pathologies such as adhesive capsulitis and rotator cuff injury.
Functional food ingredients for musculoskeletal health
Individually‑recognized functional ingredients formulated for muscle strength/cognitive support, joint/cartilage support, and bone health.
Intra‑articular injectable for knee osteoarthritis (human prescription formulation)
A prescription intra‑articular therapeutic formulation developed for knee osteoarthritis using biopolymer‑based materials.
Veterinary intra‑articular injectable (companion animals and equine)
Intra‑articular formulations developed for veterinary indications including companion dogs and racehorses.
Injectable formulations for shoulder conditions
Joint/soft‑tissue injectable formulations intended for shoulder pathologies such as adhesive capsulitis and rotator cuff injury.
Functional food ingredients for musculoskeletal health
Individually‑recognized functional ingredients formulated for muscle strength/cognitive support, joint/cartilage support, and bone health.
Services
Translational development services for connective tissue therapeutics
Preclinical study design support, formulation development for injectable therapeutics, and coordination toward clinical testing and regulatory submission.
Translational development services for connective tissue therapeutics
Preclinical study design support, formulation development for injectable therapeutics, and coordination toward clinical testing and regulatory submission.
Expertise Areas
- Connective tissue disorder therapeutics
- Intra‑articular injectable development
- Biopolymer biomaterials for therapy
- Veterinary biologics and veterinary drug development
Key Technologies
- Biopolymer biomaterials
- Injectable intra‑articular formulation
- Formulation development
- Preclinical connective tissue disease models